Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +2.96% | +4.51% | +18.80% |
13/05 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
09/05 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.80% | 101M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Clearside Biomedical Stock